Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has signed a further extension to a Virtual Tumour project with a major global pharmaceutical company, first announced on 1st March 2012. The extension will cover predicting optimal regimens for a further candidate compound and should be completed by the end of 2014...
Physiomics is pleased to announce that it has now launched its predictive web-based platform for cardiac toxicity. EasyAP™ provides cardiac action potential time course simulations to facilitate the prediction of cardiac toxicity and compound selection.
Read more....
Dr Eric Fernandez will present on Virtual Tumour technology at the ACI’s Cancer Drug Discovery & Preclinical Development conference in London, UK, which is taking place 17th and 18th of September 2014....
Physiomics is pleased to announce that it has signed a new contract with a global pharmaceutical company. The project will involve adapting the existing Virtual Tumour to model immunomodulatory agents, currently a significant focus of cancer research. The initial phase of the project will be focused on making pre-clinical predictions. If successful, the project may be extended to also adapt Virtual Tumour Clinical to immune...
Physiomics is pleased to announce that it has signed a Heads of Terms agreement with Diatech Pharmacogenetics to negotiate a Collaboration Agreement. Under the terms of the anticipated Collaboration Agreement Physiomics and Diatech will develop an innovative in-silico platform to personalize cancer patient treatment.
This anticipated new in-silico platform will combine pharmacological information related to cancer drugs with genomic and physiological information about the patient, to...
Dr Mark Chadwick, CEO and Dr Christophe Chassagnole, COO will both present at Biotrinity 2014. Dr Chadwick will present our latest technologies in the Company showcase on the 14th of May at 13:50 and Dr Christophe Chassagnole will present on Virtual Tumour Clinical in the TSB showcase on the 13th of May at 15:20.
...
Physiomics will present a half-day workshop on “Applications of Physiomics’ Virtual Tumour Clinical within Translational Science”, on the June 10, 1:30 pm – 4:30 pm ahead of the 2014 PAGE meeting that will take place in Alicante (Spain). This workshop will review the preclinical Virtual Tumour model used to predict optimal doses and schedules of combination therapy. We will provide an overview regarding the extension...
